The incidences and mortalities of major cancers in China, 2010.
about
Emerging molecular classifications and therapeutic implications for gastric cancerIncreased colorectal cancer incidence in Iran: a systematic review and meta-analysisPredictive biomarkers in precision medicine and drug development against lung cancerEtiology and Prevention of Gastric CancerCD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells.Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial.Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.Overexpression of Musashi-1 protein is associated with progression and poor prognosis of gastric cancer.MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancerDown-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor cell growth and invasion in lung adenocarcinomaNovel anti-melanoma treatment: focus on immunotherapy.Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting.LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.MiR-592 inhibited cell proliferation of human colorectal cancer cells by suppressing of CCND3 expression.Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma.Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.Factors affecting sphincter-preserving resection treatment for patients with low rectal cancer.RARRES3 suppressed metastasis through suppression of MTDH to regulate epithelial-mesenchymal transition in colorectal cancer.Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy.Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial.Secular trend analysis of lung cancer incidence in Sihui city, China between 1987 and 2011.The updated incidences and mortalities of major cancers in China, 2011Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou, 2000-2011The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.Estimation of cancer burden in Guangdong Province, China in 2009.Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomyExpert consensus on maintenance treatment for metastatic colorectal cancer in China.Clinical research of percutaneous bilateral splanchnic nerve lesion for pain relief in patients with pancreatic cancer under X-ray guidance.Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.Effect of preoperative injection of carbon nanoparticle suspension on the outcomes of selected patients with mid-low rectal cancer.Association of perioperative blood pressure with long-term survival in rectal cancer patients.Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancerLow expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients.Prognostic significance of RelB overexpression in non-small cell lung cancer patientsClinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations.The incidence and mortality of major cancers in China, 2012.Predictive model for 5-year mortality after breast cancer surgery in Taiwan residents.Diagnosis and treatment pattern among rural and urban breast cancer patients in Southwest China from 2005 to 2009.Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer.
P2860
Q26745525-DDF1F2F0-72CD-4483-A322-2A94A8B8B911Q26783797-F4999D36-C84D-4589-9CF7-36CC64A2463BQ26824536-86663F59-63DC-4A07-90CF-D971B0E10077Q28072819-217C36AB-4CCA-4838-8E0A-2C03B213C667Q30407458-2F7BF53D-411A-4DF7-A423-47C34958F42AQ33427471-9FC676E9-B178-4E1B-924F-67A055CD79E2Q33428967-6917F5E4-08C4-455C-8CB9-4E5B53480388Q33684774-D63DCB1F-0E1A-47C1-A4E1-23989D0D5AC8Q33684807-6497BC23-73B8-4CC7-80DE-23503FCA2B66Q33850309-EE86DC0E-CA82-4C11-A0F1-26EFFADCB0A3Q34309404-3D0644C0-033D-45D8-A37B-33973FAC1A4CQ35020443-C8BD415F-28DA-4C4F-9DC7-57F80C85F40CQ35304103-1E6A161C-1C18-43A3-8326-5E3B437569EBQ35643577-DAD9C3AD-6CE3-4D2E-9B4E-3B2634D18A3CQ35743521-431306C2-3AE8-4AE4-9698-2328302B6A99Q35757999-CF22B154-405F-4D49-82B1-96778E366694Q35834449-CDCA98C6-6F88-4A33-825B-3E4279D923F3Q35870113-7CCBCCD3-0EC0-4801-B8D5-43F2879B32CDQ35929836-59B75CF9-A6D0-44EA-A5B4-2A7569261472Q36043634-6786A5D7-3862-4C21-AB1B-34A23885DD20Q36121077-6F5ABEA4-71D2-4563-BEDD-767A71FBD05BQ36121131-D0412FE3-3BDF-4668-A3C0-B7030D18D041Q36121142-934E220B-ED3E-48B2-86E6-D34BC5F6B763Q36121164-3F3EDDB5-8554-4F7B-9078-A8CE8F471234Q36121363-6B1C2E7D-C790-45B0-A314-A7D4F6A38436Q36286554-625585FA-5543-4112-BF06-2F805E81F1FFQ36454673-EEE4BD9F-A8F5-4F90-ABF0-814CA75B3434Q36466880-6AEA62AD-AF4A-4AA5-9937-1F50B3F0670AQ36492627-F1895AB0-02F8-4D69-A645-1BC5597FB1E2Q36531823-0C828BDF-B314-4BF4-86B0-78EADDF19762Q36765377-B633AD3C-6B4D-4503-A5AC-1F47EABB944CQ36790373-246ECF3B-F619-4874-B805-970A5F4EEBBDQ37035451-F83A7F7F-591C-4CEE-A6BD-7C8B8D173182Q37054775-976DA143-48A1-40CA-9F1B-CB9BB3BE41DCQ37060378-B18D8A1D-DDAC-46E4-9A60-4581657D7E39Q37094986-776DC6D3-23FB-402A-AC7F-BE1F754EB858Q37148344-D5A04259-646C-44AF-A455-934B294B0B06Q37668296-A4EEC7BF-9FB0-4C0E-9D32-08428957202CQ37718506-4CC1BE08-39C0-4C45-9626-F0F92F7C64B1Q37725275-4A2BE54B-E5DA-464C-ADE9-B0C694DEABE9
P2860
The incidences and mortalities of major cancers in China, 2010.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The incidences and mortalities of major cancers in China, 2010.
@ast
The incidences and mortalities of major cancers in China, 2010.
@en
The incidences and mortalities of major cancers in China, 2010.
@nl
type
label
The incidences and mortalities of major cancers in China, 2010.
@ast
The incidences and mortalities of major cancers in China, 2010.
@en
The incidences and mortalities of major cancers in China, 2010.
@nl
prefLabel
The incidences and mortalities of major cancers in China, 2010.
@ast
The incidences and mortalities of major cancers in China, 2010.
@en
The incidences and mortalities of major cancers in China, 2010.
@nl
P2093
P356
P1476
The incidences and mortalities of major cancers in China, 2010.
@en
P2093
Hong-Mei Zeng
Rong-Shou Zheng
Si-Wei Zhang
Wan-Qing Chen
Xiao-Nong Zou
P2860
P304
P356
10.5732/CJC.014.10084
P577
2014-07-11T00:00:00Z